These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9634988)

  • 41. Augmented expression of CD44 splice variants in lymphoproliferative disorder of the lacrimal gland in Sjögren's syndrome.
    Hiraoka M; Saito I; Tsubota K; Sugai S; Miyasaka N
    Jpn J Ophthalmol; 1997; 41(5):312-8. PubMed ID: 9363560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative efficacy of androgen analogues in suppressing lacrimal gland inflammation in a mouse model (MRL/lpr) of Sjögren's syndrome.
    Rocha FJ; Sato EH; Sullivan BD; Sullivan DA
    Adv Exp Med Biol; 1994; 350():697-700. PubMed ID: 8030558
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunohistopathology of Sjögren's syndrome.
    Konttinen YT; Porola P; Konttinen L; Laine M; Poduval P
    Autoimmun Rev; 2006 Nov; 6(1):16-20. PubMed ID: 17110311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and immunological factors associated with low lacrimal and salivary flow rate in patients with primary Sjögren's syndrome.
    Pijpe J; Kalk WW; Vissink A
    J Rheumatol; 2003 Jan; 30(1):206-7; author reply 207. PubMed ID: 12508418
    [No Abstract]   [Full Text] [Related]  

  • 45. Severe focal sialadenitis and dacryoadenitis in NZM2328 mice induced by MCMV: a novel model for human Sjögren's syndrome.
    Ohyama Y; Carroll VA; Deshmukh U; Gaskin F; Brown MG; Fu SM
    J Immunol; 2006 Nov; 177(10):7391-7. PubMed ID: 17082658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormal expression and function of Fas ligand of lacrimal glands and peripheral blood in Sjögren's syndrome patients with enlarged exocrine glands.
    Tsubota K; Fujita H; Tadano K; Onoda N; Tsuzaka K; Takeuchi T
    Clin Exp Immunol; 2002 Jul; 129(1):177-82. PubMed ID: 12100038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome.
    Zoukhri D; Kublin CL
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):925-32. PubMed ID: 11274068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ultrastructural study of the lacrimal gland in a case of Sjögren's syndrome.
    Chomette G; Auriol M; Liotet S
    Scand J Rheumatol Suppl; 1986; 61():71-5. PubMed ID: 3473653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Histopathological studies of the lacrimal gland in Sjögren's syndrome. Report 3. Electron microscopy of the changes of intralobular ducts].
    Sarada K
    Nippon Ganka Gakkai Zasshi; 1982; 86(8):1025-42. PubMed ID: 7180746
    [No Abstract]   [Full Text] [Related]  

  • 50. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice.
    Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA
    Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Case of renal tubular acidosis seen in a 14-year old girl with Sjögren's syndrome].
    Shioji R; Furuyama T; Onodera S; Katsushima I; Maebashi M
    Naika; 1969 Jan; 23(1):171-7. PubMed ID: 5778379
    [No Abstract]   [Full Text] [Related]  

  • 52. [Sjögren's disease. (Morphologenetic, histochemical and immunological research on biopsies of the salivary glands)].
    Mariuzzi GM; Magni E; Malaguti R
    Riv Patol Clin Sper; 1966; 7(4):485-504. PubMed ID: 4174422
    [No Abstract]   [Full Text] [Related]  

  • 53. B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout mice.
    Hayakawa I; Tedder TF; Zhuang Y
    Immunology; 2007 Sep; 122(1):73-9. PubMed ID: 17472721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular Evidence for Precursors of Sjögren's Foci in Histologically Normal Lacrimal Glands.
    Mircheff AK; Wang Y; Pan BX; Parsa L; Nandoskar P; Ding C
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LTBR-pathway in Sjogren's syndrome: CXCL13 levels and B-cell-enriched ectopic lymphoid aggregates in NOD mouse lacrimal glands are dependent on LTBR.
    Fava RA; Browning JL; Gatumu M; Skarstein K; Bolstad AI
    Adv Exp Med Biol; 2011; 691():383-90. PubMed ID: 21153342
    [No Abstract]   [Full Text] [Related]  

  • 56. Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort.
    Suresh L; Malyavantham K; Shen L; Ambrus JL
    BMC Ophthalmol; 2015 Apr; 15():38. PubMed ID: 25881294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of steroid hormone on the salivary and lacrimal secretions in Sjögren's syndrome (author's transl)].
    Ichikawa Y; Yamauchi K; Shimizu Y; Arimori S
    Ryumachi; 1979 Feb; 19(1):15-22. PubMed ID: 424901
    [No Abstract]   [Full Text] [Related]  

  • 58. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome.
    Toda I; Sullivan BD; Rocha EM; Da Silveira LA; Wickham LA; Sullivan DA
    Exp Eye Res; 1999 Oct; 69(4):355-66. PubMed ID: 10504269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interferon alpha-2 (IFN alpha 2) increases lacrimal and salivary function in Sjögren's syndrome patients. Preliminary results of an open pilot trial versus OH-chloroquine.
    Ferraccioli GF; Salaffi F; De Vita S; Casatta L; Avellini C; Carotti M; Beltrami CA; Cervini C; Bartoli E
    Clin Exp Rheumatol; 1996; 14(4):367-71. PubMed ID: 8871834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A case of Sjögren's syndrome (author's transl)].
    Itagaki Y
    Nippon Ganka Gakkai Zasshi; 1975 Apr; 79(4):282-6. PubMed ID: 1170729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.